Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD

M. Miravitlles (Barcelona, Spain)

Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Session: Treatment and prevention of COPD exacerbation
Session type: Session
Number: 4612
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Miravitlles (Barcelona, Spain). Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD. International Congress 2017 – Treatment and prevention of COPD exacerbation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017


Macrolides in the prevention of COPD exacerbations
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012


Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014




Recommendations for bronchodilators and PDE4 inhibitors for prevention of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017


Prevention of COPD exacerbations: medications and other controversies
Source: ERJ Open Res 2015; 1: 00011-2015
Year: 2015



Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

Pharmacologic treatment of exacerbations of COPD
Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Year: 2016


Antibiotics in COPD exacerbations: practice and evidence
Source: Breathe 2009; 5: 299-301
Year: 2009

Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019



Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019



Oral immunotherapy in preventing exacerbations of COPD
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008


Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Prevention and management of COPD exacerbations
Source: International Congress 2016 – China Session II
Year: 2016


Duration of systemic corticosteroids treatment in COPD exacerbations
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008


Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010



Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Long-term azithromycin therapy in severe COPD with repeated exacerbations
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010